Analysis for HCA

📈 Growth & Financial Trajectory

Over eight quarters, Revenues rose from about $17.30B in 2023 Q4 to about $19.11B in 2026 Q1, a gain of ~10%. Net Income attributable to Parent started around $1.61B and fluctuated, peaking near $1.80B in several quarters, before a mid-2025 dip and a minor 2026 stabilization. The trend shows solid top-line growth with earnings volatility driven by mix, taxes, and non-operating items. Across the eight quarters, revenue growth outpaced earnings volatility, suggesting improving market demand but sensitivity to cost and payer mix.

💰 Margins & Cash Flow

The company sustained operating margins in the low-to-mid teens; for example, operating income around $2.0-2.4B on Revenues around $17-19B. Cash flow from operations was generally positive across quarters, with Net Cash Flow From Operating Activities often exceeding $1.5-2.0B, while investing and financing activities frequently consumed cash, resulting in occasional negative overall cash flow. Free cash flow strength appears steady but tempered by large capital needs and debt service.

🛡️ Balance Sheet & Liquidity

Total assets run around Assets near $56-61B; long-term debt stays high at roughly $40-45B; equity swings from modest positive to negative (e.g., Equity Attributable To Parent negative in multiple quarters). The balance sheet indicates substantial leverage, but liquidity from operating cash flow supports debt service; no obvious liquidity crunch across quarters shown.

⚠️ Key Drivers & Risks

• Drivers: Aging population drives inpatient demand; payer mix and pricing dynamics.
• Risks: Earnings volatility from payer reimbursements and tax items; cyclicality of elective procedures; elevated debt and occasional negative equity could pressure financial flexibility.